Telbivudine overdosage: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Telbivudine}} {{CMG}} ==Overdosage== There is no information on intentional overdose of Tyzeka, but one subject experienced an unintentional and asymptomatic over..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Telbivudine}} | {{Telbivudine}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==Overdosage== | ==Overdosage== | ||
There is no information on intentional overdose of Tyzeka, but one subject experienced an unintentional and asymptomatic overdose. Healthy subjects who received Tyzeka doses up to 1800 mg per day for 4 days had no increase in or unexpected adverse events. A maximum tolerated dose for Tyzeka has not been determined. In the event of an overdose, Tyzeka should be discontinued, the patient must be monitored for evidence of toxicity, and appropriate general supportive treatment applied as necessary.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf | publisher = |date = | accessdate = }}</ref> | There is no information on intentional overdose of Tyzeka, but one subject experienced an unintentional and asymptomatic overdose. Healthy subjects who received Tyzeka doses up to 1800 mg per day for 4 days had no increase in or unexpected adverse events. A maximum tolerated dose for Tyzeka has not been determined. In the event of an overdose, Tyzeka should be discontinued, the patient must be monitored for evidence of toxicity, and appropriate general supportive treatment applied as necessary.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
| Line 12: | Line 12: | ||
{{FDA}} | {{FDA}} | ||
[[Category: | [[Category:Antibiotics]] | ||
[[Category:Wikinfect]] | [[Category:Wikinfect]] | ||
Latest revision as of 20:57, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Overdosage
There is no information on intentional overdose of Tyzeka, but one subject experienced an unintentional and asymptomatic overdose. Healthy subjects who received Tyzeka doses up to 1800 mg per day for 4 days had no increase in or unexpected adverse events. A maximum tolerated dose for Tyzeka has not been determined. In the event of an overdose, Tyzeka should be discontinued, the patient must be monitored for evidence of toxicity, and appropriate general supportive treatment applied as necessary.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.